The costs associated with pressure ulcers are considerable. According to the Agency
for Healthcare Research & Quality (AHRQ), pressure ulcers cost the US healthcare
system an estimated $9.1-$11.6 billion annually1. In addition to direct treatment
related costs, pressure ulcers also result in litigation, government penalties, and
impact hospital performance metrics. On top of the financial implications, pressure
ulcers also have a significant impact on patient morbidity, mortality, and quality
of life. To further exacerbate the problem, as the population ages, the percent of
patients at risk for developing pressure ulcers is growing, thus increasing the demand
for early stage prevention